Real patient outcomes
Documented patient cases drawn from the Floradyle® scientific compendium and integrative clinical practice. Each case lists the protocol, the duration, the outcome and the source.
Topical: spray of diluted Floradyle® Essence (1:3) on the affected joint 2–3× daily. Oral: 1 dessertspoon morning and evening.
Pain abated significantly, joint swelling almost completely resolved, patient dispensed entirely with walking sticks within 3 weeks.
Oral: Floradyle® Essence twice daily. Topical: 1:2 diluted compress on closed eyelids (20 min). Nasal: 1:3 spray several times daily.
Sneezing attacks and watering eyes considerably improved within days; facial swelling and redness resolved after 3 days.
Mouth spray (1:1 dilution) 6–8× daily before and during chemotherapy + 1 dessertspoon Floradyle® twice daily.
Patient remained completely symptom-free of oral mucositis throughout subsequent FOLFIRI cycles, in contrast to severe toxicity on previous cycles without Floradyle®.
10 ml Floradyle® Essence Special Diet, morning and evening.
Mean uric acid 5.7 → 4.8 mg/dl at 3 months, 5.1 mg/dl at 6 months. γ-GT and ALT (liver) significantly improved. Values regressed in patients who discontinued.
Floradyle® Essence mouthwash several times a day for 3–4 weeks (Dr Peter Holzhauer protocol, Bad Trissl Hospital).
Severity scores reduced substantially across all 11 patients; mucosa healed; patients able to resume normal oral intake.
20 ml Floradyle® daily (10 ml AM + 10 ml PM) on empty stomach.
Granulocyte ATP rose 0.68 → 1.51 µM (+122%). Self-reported energy +55%, concentration +58%, physical fitness +60%.
10 ml Floradyle® twice daily before meals.
Diarrhoea severity −78%, bloating and cramps −73%; tolerability rated good or very good by 90.5% of participants.
